The Office of the United States Trade Representative is closely following issues surrounding China's rejection of U.S. corn shipments on the grounds that they included an unapproved biotech-corn variety from Syngenta. The office also encouraged the Chinese government to expedite the approval of biotech-corn varieties. "We have raised concerns with Chinese officials regarding increasing delays in the approval process for biotech events. Our expectation is that biotech approvals will be handled in a timely and predictable manner, through a transparent, science-based process," a USTR spokeswoman said.
Published in Brief: